Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

2(25%)

Results Posted

50%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_4

13%

Ph not_applicable

38%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

4(50.0%)

Phase 4Post-market surveillance

1(12.5%)

N/ANon-phased studies

3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Terminated(1)

Other(1)

Detailed Status

Completed4

Recruiting2

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 14 (50.0%)

Phase 41 (12.5%)

N/A3 (37.5%)

Trials by Status

terminated113%

unknown113%

completed450%

recruiting225%

Recent Activity

2 active trials

Showing 5 of 8

recruitingphase_1

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

NCT05959616

unknownnot_applicable

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

NCT05385887

terminatedphase_1

Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

NCT02773732

recruitingnot_applicable

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

NCT05286931

completednot_applicable

Clinical Efficacy of Crano-cure inTreatment of Urinary Tract Infection

NCT04575493

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT05959616Phase 1

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Recruiting

NCT05385887Not Applicable

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

Unknown

NCT02773732Phase 1

Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

Terminated

NCT05286931Not Applicable

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Recruiting

NCT04575493Not Applicable

Clinical Efficacy of Crano-cure inTreatment of Urinary Tract Infection

Completed

NCT01803191Phase 4

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy

Completed

NCT00785980Phase 1

Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin

Completed

NCT00138411Phase 1

Monoclonal Antibody for Treatment of Inhalation Anthrax

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8